This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier Announces Its Collaboration With Turkish Academic Network And Information Center

ANKARA, Turkey, July 1, 2013 /PRNewswire/ --


177 universities in Turkey benefit from access to Scopus and ScienceDirect for the next 3 years

Elsevier, a world-leading provider of scientific, technical, and medical information products and services, today announced its agreement with the Turkish Academic Network and Information Center (ULAKBIM) to provide 177 academic and research institutions in Turkey with access to Scopus , the largest abstract and citation database of peer-reviewed literature. In addition, access to ScienceDirect, Elsevier's full-text platform for research literature has been extended.

The 3-year agreement ensures Turkish researchers can benefit from access to high quality, world-class scholarly information resources and tools, allowing them to stay abreast of scientific developments in their fields. The previous ScienceDirect agreement with ULAKBIM provided access to 104 institutions, whereas the new agreement welcomes an additional 73 new members.

Dr. Ahmet Kaplan, Acting Director of ULAKBIM, said, "At ULAKBIM, we aim to provide our researchers with top quality scholarly information resources. Securing access to Scopus and ScienceDirect enables us to offer Turkish scientists the opportunity to broaden their global academic network and advance their research output. Our collaboration with Elsevier helps us to reach our objectives."

Tayfun Basal, Elsevier Regional Director for Turkey, Middle East and Central Asia, said, "We are pleased to see Scopus is now under national license in Turkey, similar to ScienceDirect. Access to these solutions will help Turkish scientists improve their reach within the global academic community. ULAKBIM's main goal is to provide access to scholarly information to help advance Turkey's scientific position. We are honored to support ULAKBIM in achieving this goal."

# # #

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.25 -1.10%
FB $99.97 -1.00%
GOOG $674.44 -1.40%
TSLA $152.90 6.40%
YHOO $26.51 -2.20%


Chart of I:DJI
DOW 15,557.01 -357.73 -2.25%
S&P 500 1,817.79 -34.07 -1.84%
NASDAQ 4,228.5090 -55.0830 -1.29%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs